MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 228 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,192 | +363.8% | 8,162 | +670.0% | 0.01% | +450.0% |
| Q1 2023 | $257 | -100.0% | 1,060 | -88.4% | 0.00% | -75.0% |
| Q3 2022 | $596,000 | +119.9% | 9,177 | +142.2% | 0.01% | +166.7% |
| Q2 2022 | $271,000 | +9.3% | 3,789 | +81.4% | 0.00% | -40.0% |
| Q3 2020 | $248,000 | – | 2,089 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |